Primary subtype C HIV-1 infection in Harare, Zimbabwe. 1999

P C Tien, and T Chiu, and A Latif, and S Ray, and M Batra, and C H Contag, and L Zejena, and M Mbizvo, and E L Delwart, and J I Mullins, and D A Katzenstein
Stanford University Medical Center, Center for AIDS Research, California 94305, USA.

Heterosexual transmission of HIV-1 is widespread in Southern Africa. Heteroduplex mobility assays (HMA) and phylogenetic analyses of V3-V5 envelope (env) gene sequences demonstrate that subtype C predominates in Zimbabwe. To elucidate factors contributing to the epidemic in Zimbabwe, clinical and virologic characteristics of recently acquired subtype C HIV-1 infection among 21 men and 1 woman were determined. In 12 of 19 men providing clinical histories, a sexually transmitted infection preceded serologic evidence of HIV-1, and 14 of 19 men complained of rash or fever before seroconversion. Quantitative p24 antigen levels, reverse transcriptase activity, and HIV RNA levels of 22 viral isolates correlated with in vitro infectivity in peripheral blood mononuclear cells (p < .05). Biologic phenotype assessed in MT-2 cells demonstrated that 3 of 22 isolates (14%) were syncytia inducing (SI) and the remaining 19 nonsyncytium inducing (NSI). Early growth of virus in culture was associated with increased plasma HIV RNA levels, decreased CD4 cell levels, and SI virus. Recent subtype C HIV-1 infection through heterosexual transmission in Zimbabwe demonstrated clinical and virologic features consistent with reports of seroconversion to subtype B viruses.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D003588 Cytopathogenic Effect, Viral Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. Cytopathic Effect, Viral,Viral Cytopathogenic Effect,Cytopathic Effects, Viral,Cytopathogenic Effects, Viral,Effect, Viral Cytopathic,Effect, Viral Cytopathogenic,Effects, Viral Cytopathic,Effects, Viral Cytopathogenic,Viral Cytopathic Effect,Viral Cytopathic Effects,Viral Cytopathogenic Effects
D005260 Female Females
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA

Related Publications

P C Tien, and T Chiu, and A Latif, and S Ray, and M Batra, and C H Contag, and L Zejena, and M Mbizvo, and E L Delwart, and J I Mullins, and D A Katzenstein
July 1997, The Central African journal of medicine,
P C Tien, and T Chiu, and A Latif, and S Ray, and M Batra, and C H Contag, and L Zejena, and M Mbizvo, and E L Delwart, and J I Mullins, and D A Katzenstein
August 2002, Journal of acquired immune deficiency syndromes (1999),
P C Tien, and T Chiu, and A Latif, and S Ray, and M Batra, and C H Contag, and L Zejena, and M Mbizvo, and E L Delwart, and J I Mullins, and D A Katzenstein
January 2002, HIV clinical trials,
P C Tien, and T Chiu, and A Latif, and S Ray, and M Batra, and C H Contag, and L Zejena, and M Mbizvo, and E L Delwart, and J I Mullins, and D A Katzenstein
April 1997, East African medical journal,
P C Tien, and T Chiu, and A Latif, and S Ray, and M Batra, and C H Contag, and L Zejena, and M Mbizvo, and E L Delwart, and J I Mullins, and D A Katzenstein
December 1999, Sexually transmitted infections,
P C Tien, and T Chiu, and A Latif, and S Ray, and M Batra, and C H Contag, and L Zejena, and M Mbizvo, and E L Delwart, and J I Mullins, and D A Katzenstein
January 2019, Southern African journal of HIV medicine,
P C Tien, and T Chiu, and A Latif, and S Ray, and M Batra, and C H Contag, and L Zejena, and M Mbizvo, and E L Delwart, and J I Mullins, and D A Katzenstein
June 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
P C Tien, and T Chiu, and A Latif, and S Ray, and M Batra, and C H Contag, and L Zejena, and M Mbizvo, and E L Delwart, and J I Mullins, and D A Katzenstein
November 2009, AIDS (London, England),
P C Tien, and T Chiu, and A Latif, and S Ray, and M Batra, and C H Contag, and L Zejena, and M Mbizvo, and E L Delwart, and J I Mullins, and D A Katzenstein
June 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
P C Tien, and T Chiu, and A Latif, and S Ray, and M Batra, and C H Contag, and L Zejena, and M Mbizvo, and E L Delwart, and J I Mullins, and D A Katzenstein
October 1991, The Central African journal of medicine,
Copied contents to your clipboard!